bpc-157 human clinical trial 2024 Hits a Milestone: The First Controlled Is Now Recruiting | PeptIQ Blog BPC-157: What the Science Says

In the research framing, judging the protocol by the fast signal is a mistake the endpoint that carries the human data is the slow one

Merrifield, R.B

Because mucus hypersecretion and mucus obstruction are common features of many airway diseases, we place special emphasis on the contribution of neuropeptides to mucus secretion

The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication

A 2023 study found viral RNA and protein in multiple tissue sites, including the gut, lymph nodes, and brain, up to 12 months post-infection in some patients

ASeek urgent medical care if you experience difficulty breathing, swelling of the face, lips, tongue, or throat, severe rash, chest tightness, fainting, or any signs of a severe allergic reaction after receiving the injection